BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21621563)

  • 21. Computational identification and modeling of crosstalk between phosphorylation, O-β-glycosylation and methylation of FoxO3 and implications for cancer therapeutics.
    Butt AM; Feng D; Idrees M; Tong Y; Lu J
    Int J Mol Sci; 2012; 13(3):2918-2938. PubMed ID: 22489133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FLT3 ligand regulates apoptosis through AKT-dependent inactivation of transcription factor FoxO3.
    Jönsson M; Engström M; Jönsson JI
    Biochem Biophys Res Commun; 2004 Jun; 318(4):899-903. PubMed ID: 15147956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FoxO3 controls autophagy in skeletal muscle in vivo.
    Mammucari C; Milan G; Romanello V; Masiero E; Rudolf R; Del Piccolo P; Burden SJ; Di Lisi R; Sandri C; Zhao J; Goldberg AL; Schiaffino S; Sandri M
    Cell Metab; 2007 Dec; 6(6):458-71. PubMed ID: 18054315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
    Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
    BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases.
    Ni YG; Wang N; Cao DJ; Sachan N; Morris DJ; Gerard RD; Kuro-O M; Rothermel BA; Hill JA
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20517-22. PubMed ID: 18077353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.
    Rena G; Prescott AR; Guo S; Cohen P; Unterman TG
    Biochem J; 2001 Mar; 354(Pt 3):605-12. PubMed ID: 11237865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor.
    Greer EL; Oskoui PR; Banko MR; Maniar JM; Gygi MP; Gygi SP; Brunet A
    J Biol Chem; 2007 Oct; 282(41):30107-19. PubMed ID: 17711846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics.
    Jacobs FM; van der Heide LP; Wijchers PJ; Burbach JP; Hoekman MF; Smidt MP
    J Biol Chem; 2003 Sep; 278(38):35959-67. PubMed ID: 12857750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of FoxO transcription factors by acetylation and protein-protein interactions.
    Daitoku H; Sakamaki J; Fukamizu A
    Biochim Biophys Acta; 2011 Nov; 1813(11):1954-60. PubMed ID: 21396404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
    Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
    Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-step activation of FOXO3 by AMPK generates a coherent feed-forward loop determining excitotoxic cell fate.
    Davila D; Connolly NM; Bonner H; Weisová P; Dussmann H; Concannon CG; Huber HJ; Prehn JH
    Cell Death Differ; 2012 Oct; 19(10):1677-88. PubMed ID: 22539004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
    Moylan JS; Smith JD; Chambers MA; McLoughlin TJ; Reid MB
    Am J Physiol Cell Physiol; 2008 Oct; 295(4):C986-93. PubMed ID: 18701653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17β-Estradiol Prevents Extracellular Matrix Degradation by Downregulating MMP3 Expression via PI3K/Akt/FOXO3 Pathway.
    Gao XW; Su XT; Lu ZH; Ou J
    Spine (Phila Pa 1976); 2020 Mar; 45(5):292-299. PubMed ID: 31809475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid-induced leucine zipper (GILZ) promotes the nuclear exclusion of FOXO3 in a Crm1-dependent manner.
    Latré de Laté P; Pépin A; Assaf-Vandecasteele H; Espinasse C; Nicolas V; Asselin-Labat ML; Bertoglio J; Pallardy M; Biola-Vidamment A
    J Biol Chem; 2010 Feb; 285(8):5594-605. PubMed ID: 20018851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-β-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation.
    Kurebayashi Y; Baba Y; Minowa A; Nadya NA; Azuma M; Yoshimura A; Koyasu S; Nagai S
    Biochem Biophys Res Commun; 2016 Nov; 480(1):114-119. PubMed ID: 27697523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease.
    Du X; Shi H; Li J; Dong Y; Liang J; Ye J; Kong S; Zhang S; Zhong T; Yuan Z; Xu T; Zhuang Y; Zheng B; Geng JG; Tao W
    J Immunol; 2014 Feb; 192(4):1525-35. PubMed ID: 24453252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AKT and 14-3-3 regulate Notch4 nuclear localization.
    Ramakrishnan G; Davaakhuu G; Chung WC; Zhu H; Rana A; Filipovic A; Green AR; Atfi A; Pannuti A; Miele L; Tzivion G
    Sci Rep; 2015 Mar; 5():8782. PubMed ID: 25740432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways.
    Cahill CM; Tzivion G; Nasrin N; Ogg S; Dore J; Ruvkun G; Alexander-Bridges M
    J Biol Chem; 2001 Apr; 276(16):13402-10. PubMed ID: 11124266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of PIK3 signaling pathway members by the ovotoxicant 4-vinylcyclohexene diepoxide in rats.
    Keating AF; Fernandez SM; Mark-Kappeler CJ; Sen N; Sipes IG; Hoyer PB
    Biol Reprod; 2011 Apr; 84(4):743-51. PubMed ID: 21076081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.